|
||||||
|
 | |
| |
| |
| |
| |
|
Fusion gene ID: 1425 |
FusionGeneSummary for ALAS1_PARP3 |
 Fusion gene summary |
| Fusion gene information | Fusion gene name: ALAS1_PARP3 | Fusion gene ID: 1425 | Hgene | Tgene | Gene symbol | ALAS1 | PARP3 | Gene ID | 211 | 10039 |
| Gene name | 5'-aminolevulinate synthase 1 | poly(ADP-ribose) polymerase family member 3 | |
| Synonyms | ALAS|ALAS-H|ALAS3|ALASH|MIG4 | ADPRT3|ADPRTL2|ADPRTL3|ARTD3|IRT1|PADPRT-3 | |
| Cytomap | 3p21.2 | 3p21.2 | |
| Type of gene | protein-coding | protein-coding | |
| Description | 5-aminolevulinate synthase, nonspecific, mitochondrial5-aminolevulinic acid synthase 1aminolevulinate, delta-, synthase 1delta-ALA synthase 1delta-aminolevulinate synthase 1migration-inducing protein 4 | poly [ADP-ribose] polymerase 3ADP-ribosyltransferase (NAD+; poly (ADP-ribose) polymerase)-like 2ADP-ribosyltransferase (NAD+; poly (ADP-ribose) polymerase)-like 3ADP-ribosyltransferase diphtheria toxin-like 3ADPRT-3NAD(+) ADP-ribosyltransferase 3NAD | |
| Modification date | 20180522 | 20180523 | |
| UniProtAcc | P13196 | Q9Y6F1 | |
| Ensembl transtripts involved in fusion gene | ENST00000469224, ENST00000394965, ENST00000310271, ENST00000484952, | ENST00000417220, ENST00000431474, ENST00000398755, ENST00000486510, | |
| Fusion gene scores | * DoF score | 4 X 4 X 4=64 | 1 X 1 X 1=1 |
| # samples | 4 | 1 | |
| ** MAII score | log2(4/64*10)=-0.678071905112638 possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs). DoF>8 and MAII<0 | log2(1/1*10)=3.32192809488736 | |
| Context | PubMed: ALAS1 [Title/Abstract] AND PARP3 [Title/Abstract] AND fusion [Title/Abstract] | ||
| Functional or gene categories assigned by FusionGDB annotation | |||
| * DoF score (Degree of Frequency) = # partners X # break points X # cancer types ** MAII score (Major Active Isofusion Index) = log2(# samples/DoF score*10) |
| Gene ontology of each fusion partner gene with evidence of Inferred from Direct Assay (IDA) from Entrez |
| Partner | Gene | GO ID | GO term | PubMed ID |
| Tgene | PARP3 | GO:0006302 | double-strand break repair | 21270334 |
| Tgene | PARP3 | GO:0006471 | protein ADP-ribosylation | 21270334 |
| Fusion gene information from three resources (ChiTars (NAR, 2018), tumorfusions (NAR, 2018), Gao et al. (Cell, 2018)) * All genome coordinats were lifted-over on hg19. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
| Data type | Source | Cancer type | Sample | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
| TCGA | RV | LUSC | TCGA-85-8479-01A | ALAS1 | chr3 | 52232271 | + | PARP3 | chr3 | 51981756 | + |
| * LD: Li Ding group's fusion gene list RV: Roel Verhaak group's fusion gene list ChiTaRs fusion database |
| Open reading frame (ORF) analsis of fusion genes based on Ensembl gene isoform structure. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
| ORF | Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
| 5UTR-3CDS | ENST00000469224 | ENST00000417220 | ALAS1 | chr3 | 52232271 | + | PARP3 | chr3 | 51981756 | + |
| 5UTR-3CDS | ENST00000469224 | ENST00000431474 | ALAS1 | chr3 | 52232271 | + | PARP3 | chr3 | 51981756 | + |
| 5UTR-3CDS | ENST00000469224 | ENST00000398755 | ALAS1 | chr3 | 52232271 | + | PARP3 | chr3 | 51981756 | + |
| 5UTR-3UTR | ENST00000469224 | ENST00000486510 | ALAS1 | chr3 | 52232271 | + | PARP3 | chr3 | 51981756 | + |
| 5UTR-3CDS | ENST00000394965 | ENST00000417220 | ALAS1 | chr3 | 52232271 | + | PARP3 | chr3 | 51981756 | + |
| 5UTR-3CDS | ENST00000394965 | ENST00000431474 | ALAS1 | chr3 | 52232271 | + | PARP3 | chr3 | 51981756 | + |
| 5UTR-3CDS | ENST00000394965 | ENST00000398755 | ALAS1 | chr3 | 52232271 | + | PARP3 | chr3 | 51981756 | + |
| 5UTR-3UTR | ENST00000394965 | ENST00000486510 | ALAS1 | chr3 | 52232271 | + | PARP3 | chr3 | 51981756 | + |
| 5UTR-3CDS | ENST00000310271 | ENST00000417220 | ALAS1 | chr3 | 52232271 | + | PARP3 | chr3 | 51981756 | + |
| 5UTR-3CDS | ENST00000310271 | ENST00000431474 | ALAS1 | chr3 | 52232271 | + | PARP3 | chr3 | 51981756 | + |
| 5UTR-3CDS | ENST00000310271 | ENST00000398755 | ALAS1 | chr3 | 52232271 | + | PARP3 | chr3 | 51981756 | + |
| 5UTR-3UTR | ENST00000310271 | ENST00000486510 | ALAS1 | chr3 | 52232271 | + | PARP3 | chr3 | 51981756 | + |
| 5UTR-3CDS | ENST00000484952 | ENST00000417220 | ALAS1 | chr3 | 52232271 | + | PARP3 | chr3 | 51981756 | + |
| 5UTR-3CDS | ENST00000484952 | ENST00000431474 | ALAS1 | chr3 | 52232271 | + | PARP3 | chr3 | 51981756 | + |
| 5UTR-3CDS | ENST00000484952 | ENST00000398755 | ALAS1 | chr3 | 52232271 | + | PARP3 | chr3 | 51981756 | + |
| 5UTR-3UTR | ENST00000484952 | ENST00000486510 | ALAS1 | chr3 | 52232271 | + | PARP3 | chr3 | 51981756 | + |
Top |
FusionProtFeatures for ALAS1_PARP3 |
| Main function of each fusion partner protein. (from UniProt) |
| Hgene | Tgene |
| ALAS1 | PARP3 |
| Involved in the base excision repair (BER) pathway, bycatalyzing the poly(ADP-ribosyl)ation of a limited number ofacceptor proteins involved in chromatin architecture and in DNAmetabolism. This modification follows DNA damages and appears asan obligatory step in a detection/signaling pathway leading to thereparation of DNA strand breaks. May link the DNA damagesurveillance network to the mitotic fidelity checkpoint.Negatively influences the G1/S cell cycle progression withoutinterfering with centrosome duplication. Binds DNA. May beinvolved in the regulation of PRC2 and PRC3 complex-dependent genesilencing. {ECO:0000269|PubMed:16924674}. |
| Retention analysis result of each fusion partner protein across 39 protein features of UniProt such as six molecule processing features, 13 region features, four site features, six amino acid modification features, two natural variation features, five experimental info features, and 3 secondary structure features. Here, because of limited space for viewing, we only show the protein feature retention information belong to the 13 regional features. All retention annotation result can be downloaded at . * Minus value of BPloci means that the break pointn is located before the CDS. |
| - In-frame and retained protein feature among the 13 regional features. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
| - In-frame and not-retained protein feature among the 13 regional features. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
Top |
FusionGeneSequence for ALAS1_PARP3 |
| For in-frame fusion transcripts, we provide the fusion transcript sequences and fusion amino acid sequences. (nt: nucleotides, aa: amino acids) |
| * Fusion amino acid sequences. |
| * Fusion transcript sequences (only coding sequence (CDS) region). |
| * Fusion transcript sequences (Full-length transcript). |
Top |
FusionGenePPI for ALAS1_PARP3 |
| Go to ChiPPI (Chimeric Protein-Protein interactions) to see the chimeric PPI interaction in . |
| Protein-protein interactors with each fusion partner protein in wild-type (BIOGRID-3.4.160) |
| Hgene | Hgene's interactors | Tgene | Tgene's interactors |
| ALAS1 | CDK5, RAP1B, NUDT3, TK1, CDKN1A, SUMO2, C8orf33, PIK3CB, STAMBP, VHL, PLAU, ALAS1, BCL7A, PPL, TCEA2, TMSB4X, TMSB4XP1, TMSB4XP2, TMSB4XP6, WIPF1, ZNF175, TMSB10, USP20, ZFYVE26, POLDIP2, CCHCR1, GNL3L, C2orf42, EP400, SH2D4A, CERK, TTC23, CDC73, ZMAT1, LONRF1, MTFR2, SNX20, DUSP19, TEKT4, ZNF564, KLHL35, FAM127C, MOV10, NXF1, HMGCL, OXLD1, RCHY1, TMOD3, THEM4, MCAT, TMOD4, ECHDC2, TRMT61B, NDUFS6, FDPS, CAMK2D, PCK2 | PARP3 | RPA3, MTHFD2, HIST2H2BE, HIST2H3C, PARP1, PARP3, HIST1H1A, APP |
| - Retained PPIs in in-frame fusion. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Still interaction with |
| - Lost PPIs in in-frame fusion. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
| - Retained PPIs, but lost function due to frame-shift fusion. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
Top |
RelatedDrugs for ALAS1_PARP3 |
| Drugs targeting genes involved in this fusion gene. (DrugBank Version 5.1.0 2018-04-02) |
| Partner | Gene | UniProtAcc | DrugBank ID | Drug name | Drug activity | Drug type | Drug status |
| Hgene | ALAS1 | P13196 | DB00114 | Pyridoxal Phosphate | 5-aminolevulinate synthase, nonspecific, mitochondrial | small molecule | approved|investigational|nutraceutical |
| Hgene | ALAS1 | P13196 | DB00145 | Glycine | 5-aminolevulinate synthase, nonspecific, mitochondrial | small molecule | approved|nutraceutical|vet_approved |
| Tgene | PARP3 | Q9Y6F1 | DB09074 | Olaparib | Poly [ADP-ribose] polymerase 3 | small molecule | approved |
Top |
RelatedDiseases for ALAS1_PARP3 |
| Diseases associated with fusion partners. (DisGeNet 4.0) |
| Partner | Gene | Disease ID | Disease name | # pubmeds | Source |
| Hgene | ALAS1 | C0032708 | Disorders of Porphyrin Metabolism | 1 | CTD_human |
Copyright 2018-Present -The University of Texas Health Science Center at Houston (UTHealth)
|